Ozuriftamab vedotin | Antioxidant inhibitor | Read Reviews & Product Use Citations

Ozuriftamab vedotin (BA 3021) is an antibody-drug conjugate (ADC) composed of ozuriftamab, a conditionally active biologic (CAB) antibody against receptor tyrosine kinase-like orphan receptor 2 (ROR2) conjugated to monomethyl auristatin E, with potential antineoplastic activity.

CAS No. 2460400-11-5

Click to purchase products related to Ozuriftamab vedotin

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 4.22mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective Antioxidant Inhibitors

Biological Activity

Description	Ozuriftamab vedotin (BA 3021) is an antibody-drug conjugate (ADC) composed of ozuriftamab, a conditionally active biologic (CAB) antibody against receptor tyrosine kinase-like orphan receptor 2 (ROR2) conjugated to monomethyl auristatin E, with potential antineoplastic activity.

Product Details

CAS No.	2460400-11-5
ADC antiody	Ozuriftamab
ADC cytotoxin	MMAE
Formulation	1xPBS
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field